Unit 1 · Foundations & the SMAS
Facial muscles insert into skin, and everything follows from that
The muscles of facial expression behave unlike any other muscle group in the body because most of them attach to dermis rather than bone. This unit establishes that principle, the agonist–antagonist balance that governs how a treated muscle changes the face, and the SMAS — the layer that couples muscle contraction to visible skin movement and defines the planes you inject into.
Framing
What makes a mimetic muscle different
The facial muscles — collectively termed the muscles of facial expression, or mimetic muscles — are unique in that the majority insert directly into the dermis rather than into bone.
That direct dermal attachment is what enables the skin to move and form the full range of human expression. It is also what makes these muscles highly relevant to aesthetic practitioners: both their contractile function and their atrophy determine the texture, volume distribution and dynamic line formation that underpin the ageing face.
Unlike the muscles of the limbs, most facial muscles are derived from the second pharyngeal arch and are innervated by the facial nerve (cranial nerve VII). Understanding the branching anatomy of CN VII is inseparable from understanding facial muscle anatomy — injury to any branch, whether from trauma, surgical dissection or a misplaced injection, produces predictable functional deficit.
The facial muscles are broadly organised by region: the forehead and scalp, the periorbital region, the nose, the cheeks and midface, the perioral region, and the neck. Units 2 to 4 work through those regions in turn.
The facial muscles are generally thin, flat and difficult to palpate in isolation. In clinical practice their position is inferred through movement: asking a patient to raise their brows, squint, smile or pucker will reliably activate specific muscle groups. This dynamic assessment is the foundation of injectable treatment planning.
The anatomical feature that distinguishes the muscles of facial expression from the muscles of the limbs, and that explains why they produce visible skin change, is:
Select an option to commit. The reasoning appears afterwards.
The majority of mimetic muscles insert into dermis, not bone. That single fact is why contraction moves skin rather than moving a joint, and why both muscle activity and muscle atrophy show up on the surface as texture, volume distribution and dynamic line formation.
It also sets the terms for assessment. Because these muscles are thin, flat and largely unpalpable, you locate them by asking the patient to move — brows up, squint, smile, pucker. Every treatment plan in this module starts from what the face does, not from what you can feel.
Predict · Muscle balance
Why weakening one muscle changes the behaviour of another
No facial muscle acts alone. Elevators and depressors work against each other across the same piece of skin, and the resting position of a feature is the balance point between them. Before reading on, commit to what happens when that balance is disturbed on one side of the equation only.
A depressor muscle is weakened with a neuromodulator and the treated muscle behaves exactly as intended — so why can the result still be asymmetric?
Hold your answer before you open this. The value is in having committed to a mechanism first.
The concept of agonist–antagonist muscle balance is central to advanced neuromodulator practice. Weakening a depressor muscle, for example the depressor anguli oris, without considering the pull of its antagonist elevator, for example the zygomaticus major, can produce asymmetry.
Comprehensive anatomical knowledge allows the practitioner to predict and correct these imbalances. The muscle you treated is only half the picture — the other half is whatever is now pulling unopposed.
Read the whole face as a set of opposing pairs rather than as a list of targets. Unit 3 works through the perioral complex, where multiple depressors and elevators converge on a single fibromuscular node, the modiolus — the point at which an imbalance introduced anywhere in the complex becomes visible everywhere in it.
Understanding muscle origin and insertion points is clinically important in neuromodulator injection because:
Select an option to commit. The reasoning appears afterwards.
Origin and insertion together describe the vector of a muscle — which structure it pulls, in which direction. Knowing that vector is what lets you say in advance what the face will do once the muscle is weakened, and it is what tells you where along the muscle to place product to achieve that and nothing more.
The same knowledge is your margin of safety. A muscle's course tells you what lies immediately medial, lateral, deep and superficial to your intended point, which is how you avoid weakening the neighbour instead of the target. Units 2 to 4 apply this muscle by muscle.
Learn · The SMAS
The superficial musculoaponeurotic system
The SMAS is a fibromuscular layer that envelops the muscles of facial expression, connecting them to the overlying dermis and the underlying deep facial fascia.
First described by Mitz and Peyronie in 1974, it represents one of the most clinically significant anatomical concepts in aesthetic medicine. The SMAS is continuous with the platysma inferiorly, the temporoparietal fascia superiorly, and the galea aponeurotica of the scalp. It acts as a mechanical coupling between muscle contraction and skin movement — the reason a smile produces cheek elevation rather than simply wrinkling the overlying skin in isolation.
In the midface, the SMAS is intimately associated with the retaining ligaments — osteocutaneous and fibromuscular ligaments that anchor the soft tissue to the underlying skeleton. As these ligaments weaken with age, the SMAS and attached soft tissue descend, producing the characteristic features of facial ageing: deepening nasolabial folds, jowling, and loss of the acute cervicomental angle.
| Structure | Continuity | Clinical significance |
|---|---|---|
| SMAS proper | Platysma (inferior), temporoparietal fascia (superior) | Primary surgical plane in rhytidectomy; injectable reference layer |
| Galea aponeurotica | SMAS (via frontalis) | Transmits frontalis contraction across scalp |
| Platysma | SMAS (superior), pectoral fascia (inferior) | Neck banding; neuromodulator target for Nefertiti lift |
| Retaining ligaments | Anchor SMAS to periosteum / dermis | Laxity contributes to ptosis; injection release technique described |
Two injections deliver the same product, in the same region, at the same volume — one above the SMAS and one deep to the muscle. Why is the safety profile of those two injections not the same?
Hold your answer before you open this. The value is in having committed to a mechanism first.
Filler placement relative to the SMAS determines both the aesthetic result and the safety profile of an injection. Supraperiosteal placement, deep to muscle, is generally the safest plane for high-volume structural augmentation.
Subdermal placement above the SMAS carries a higher vascular risk in areas where named vessels run within or immediately superficial to this layer. A clear mental model of the SMAS plane is therefore essential for safe deep-plane work.
The SMAS is also the reason a treatment aimed at one structure can express itself somewhere else. Because the layer is continuous from galea to platysma, tension applied at one end of the system is transmitted along it — which is the anatomical basis for treating the platysma to influence jawline definition, covered in Unit 4.
You are planning high-volume structural augmentation over bone in the midface. On the basis of the SMAS anatomy, the plane generally regarded as the safest for that purpose is:
Select an option to commit. The reasoning appears afterwards.
Supraperiosteal placement, deep to muscle, is generally the safest plane for high-volume structural augmentation. It sits beneath the layer in which the mimetic muscles and their associated vasculature run, so the product is deposited against bone rather than alongside named vessels.
The comparison is the point. Subdermal placement above the SMAS carries a higher vascular risk wherever named vessels run within or immediately superficial to that layer. Depth is not a technique preference in this region — it is the variable that changes the risk profile of an otherwise identical injection.
Unit 1 summary
Clinical takeaways
- Dermal insertion is the defining feature. Most mimetic muscles attach to skin rather than bone, which is why their contraction and their atrophy both present as surface change, and why position is inferred through movement rather than palpation.
- Attachment points predict outcome. Origin and insertion describe the direction a muscle pulls, which is what allows the functional effect of weakening it to be anticipated before the needle goes in.
- Muscles work in opposing pairs. Weakening a depressor without accounting for the pull of its antagonist elevator can produce asymmetry. The muscle left unopposed is as relevant as the muscle treated.
- The SMAS defines the planes. It couples muscle contraction to skin movement and separates supraperiosteal placement, generally the safest plane for high-volume structural augmentation, from subdermal placement above the SMAS, which carries higher vascular risk where named vessels run in or just superficial to that layer.